NYSEAMERICAN:NSPRInspireMD Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding InspireMD Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.60 +0.02 (+3.43 %) (As of 04/8/2020 02:52 PM ET) Add Compare Share Today's Range$0.56Now: $0.60▼$0.6250-Day Range$1.34MA: $2.42▼$3.5952-Week Range$0.48Now: $0.60▼$7.51Volume35,305 shsAverage Volume218,879 shsMarket Capitalization$2.62 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingInspireMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.00, InspireMD has a potential upside of 231.4% from its current price of $0.60.Amount of Analyst CoverageInspireMD has only been the subject of 1 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesInspireMD has received 185 “outperform” votes. (Add your “outperform” vote.)Underperform VotesInspireMD has received 181 “underperform” votes. (Add your “underperform” vote.)Community SentimentInspireMD has received 50.55% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about InspireMD and other stocks. Vote “Outperform” if you believe NSPR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NSPR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldInspireMD does not currently pay a dividend.Dividend GrowthInspireMD does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InspireMD insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.20 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Medical Appliances & Equipment Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:NSPR Previous SymbolNASDAQ:NSPR CUSIPN/A CIK1433607 Webhttp://www.inspiremd.com/ Phone+1-857-4536553Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees43 Outstanding Shares4,339,000Market Cap$2.62 million Next Earnings Date5/12/2020 (Estimated) OptionableNot Optionable Receive NSPR News and Ratings via Email Sign-up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. AMEX:NSPR Rates by TradingView InspireMD (NYSEAMERICAN:NSPR) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of InspireMD? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for InspireMD. When is InspireMD's next earnings date? InspireMD is scheduled to release its next quarterly earnings announcement on Tuesday, May 12th 2020. View our earnings forecast for InspireMD. How were InspireMD's earnings last quarter? InspireMD Inc (NYSEAMERICAN:NSPR) issued its quarterly earnings data on Tuesday, March, 10th. The medical equipment provider reported ($0.57) EPS for the quarter, hitting analysts' consensus estimates of ($0.57). The medical equipment provider had revenue of $1.01 million for the quarter. View InspireMD's earnings history. When did InspireMD's stock split? How did InspireMD's stock split work? InspireMD's stock reverse split on Monday, April 1st 2019. The 1-50 reverse split was announced on Tuesday, March 26th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 29th 2019. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 2 shares after the split. What price target have analysts set for NSPR? 1 brokers have issued twelve-month price objectives for InspireMD's stock. Their forecasts range from $2.00 to $2.00. On average, they anticipate InspireMD's stock price to reach $2.00 in the next year. This suggests a possible upside of 231.4% from the stock's current price. View analysts' price targets for InspireMD. What are Wall Street analysts saying about InspireMD stock? Here are some recent quotes from research analysts about InspireMD stock: 1. According to Zacks Investment Research, "InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel. " (3/31/2020) 2. HC Wainwright analysts commented, "Our $5 PT was derived by using a 25% weighted-average cost of capital to discount free cash flows we project 2019-2030, and dividing them by our projected number of shares for each year to account for the effects of share dilution, and then ascribing a 1% terminal growth rate and 75% probability of." (8/19/2019) Has InspireMD been receiving favorable news coverage? News stories about NSPR stock have been trending very negative on Wednesday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. InspireMD earned a coverage optimism score of -3.3 on InfoTrie's scale. They also gave news articles about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutInspireMD. Are investors shorting InspireMD? InspireMD saw a decline in short interest during the month of February. As of February 28th, there was short interest totaling 91,200 shares, a decline of 39.5% from the February 13th total of 150,700 shares. Based on an average trading volume of 228,600 shares, the short-interest ratio is presently 0.4 days. Approximately 7.9% of the shares of the company are sold short. View InspireMD's Current Options Chain. Who are some of InspireMD's key competitors? Some companies that are related to InspireMD include Deltex Medical Group (DEMG), Zecotek Photonics (ZMS), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS). What other stocks do shareholders of InspireMD own? Based on aggregate information from My MarketBeat watchlists, some companies that other InspireMD investors own include Palatin Technologies (PTN), Novavax (NVAX), NovaBay Pharmaceuticals (NBY), TransEnterix (TRXC), Inovio Pharmaceuticals (INO), Catalyst Pharmaceuticals (CPRX), Vascular Biogenics (VBLT), Nokia Oyj (NOK), AVEO Pharmaceuticals (AVEO) and Biocept (BIOC). Who are InspireMD's key executives? InspireMD's management team includes the following people: Dr. James J. Barry, Pres, CEO & Director (Age 60)Mr. Craig Shore, CFO, Chief Admin. Officer, Sec. & Treasurer (Age 58)Mr. Agustin V. Gago, Exec. VP & Chief Commercial Officer (Age 59)Mr. Roei Samuri, VP of OperationsDr. Sol J. Barer, Special Advisor to the Board (Age 72) What is InspireMD's stock symbol? InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR." How do I buy shares of InspireMD? Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is InspireMD's stock price today? One share of NSPR stock can currently be purchased for approximately $0.60. How big of a company is InspireMD? InspireMD has a market capitalization of $2.62 million. InspireMD employs 43 workers across the globe. View additional information about InspireMD. What is InspireMD's official website? The official website for InspireMD is http://www.inspiremd.com/. How can I contact InspireMD? InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553. This page was last updated on 4/8/2020 by MarketBeat.com StaffFeatured Article: How is the LIBOR rate calculated?
